Authors:
HOWARD TE
MCRITCHIE B
SAWYER PJT
WALLIS RM
Citation: Te. Howard et al., EFFECT OF DARIFENACIN AND OTHER MUSCARINIC ANTAGONISTS ON GASTRIC-ACID SECRETION IN CONSCIOUS DOGS, British Journal of Pharmacology, 123, 1998, pp. 191-191
Citation: Cm. Smith et Rm. Wallis, CHARACTERIZATION OF [H-3] DARIFENACIN AS A NOVEL RADIOLIGAND FOR THE STUDY OF MUSCARINIC M(3) RECEPTORS, Journal of receptor and signal transduction research, 17(1-3), 1997, pp. 177-184
Citation: Rm. Wallis et Cm. Smith, A COMPARISON OF THE BINDING PROFILE OF ANTAGONISTS AT THE HUMAN CLONED MUSCARINIC RECEPTORS M(1) AND M(3) USING [H-3] DARIFENACIN AND [H-3]NMS, Life sciences, 60(13-14), 1997, pp. 25-25
Citation: Cl. Davies et al., IN-VIVO CHARACTERIZATION OF THE BLOOD-PRESSURE RESPONSE TO ENDOTHELIN-1 IN THE ANESTHETIZED MINIPIG, British Journal of Pharmacology, 122, 1997, pp. 404-404
Citation: P. Quinn et al., IN-VIVO PROFILE OF DARIFENACIN, A SELECTIVE MUSCARINIC M(3) RECEPTOR ANTAGONIST, British Journal of Pharmacology, 119, 1996, pp. 198-198
Authors:
SAWYER PJT
MCRITCHIE B
MERNER PA
SLOWE SJ
WALLIS RM
Citation: Pjt. Sawyer et al., IN-VIVO GUT SELECTIVITY OF THE NOVEL MUSCARINIC ANTAGONIST, DARIFENACIN, IN THE CONSCIOUS DOG, British Journal of Pharmacology, 118, 1996, pp. 144-144
Authors:
NUNN PA
GREENGRASS PM
NEWGREEN DT
NAYLOR AM
WALLIS RM
Citation: Pa. Nunn et al., THE BINDING PROFILE OF THE NOVEL MUSCARINIC RECEPTOR ANTAGONIST DARIFENACIN AGAINST THE 5 CLONED HUMAN MUSCARINIC RECEPTORS EXPRESSED IN CHO CELLS, British Journal of Pharmacology, 117, 1996, pp. 130-130
Citation: Rm. Wallis, PRECLINICAL AND CLINICAL-PHARMACOLOGY OF SELECTIVE MUSCARINIC M(3) RECEPTOR ANTAGONISTS, Life sciences, 56(11-12), 1995, pp. 861-868
Citation: Pm. Kerr et al., PHARMACOLOGICAL CHARACTERIZATION OF MUSCARINIC RECEPTORS MEDIATING CONTRACTILITY IN HUMAN COLON, Life sciences, 56(11-12), 1995, pp. 1042-1042
Citation: Fa. Aston et al., CHARACTERIZATION OF THE MUSCARINIC RECEPTOR SUBTYPES INVOLVED IN THE HABITUATION RESPONSE IN THE RAT, British Journal of Pharmacology, 115, 1995, pp. 87-87
Citation: Pm. Kerr et al., CHARACTERIZATION OF MUSCARINIC RECEPTORS MEDIATING CONTRACTIONS OF CIRCULAR AND LONGITUDINAL MUSCLE OF HUMAN ISOLATED COLON, British Journal of Pharmacology, 115(8), 1995, pp. 1518-1524
Citation: Pm. Kerr et al., PHARMACOLOGICAL CHARACTERIZATION OF MUSCARINIC RECEPTORS MEDIATING CONTRACTION OF HUMAN COLONIC SMOOTH-MUSCLE, British Journal of Pharmacology, 112, 1994, pp. 210000017-210000017
Authors:
QUINN P
ASTON FA
ADDLEY N
HALFPENNY P
WALLIS RM
Citation: P. Quinn et al., THE CARDIOVASCULAR EFFECTS OF 5-HT1A SELECTIVE COMPOUNDS - ANTAGONISTSTUDIES WITH WAY-100,135, British Journal of Pharmacology, 112, 1994, pp. 210000066-210000066
Citation: P. Quinn et Rm. Wallis, UK-84,149 - A POTENT AND GUT-SELECTIVE SPASMOLYTIC IN THE ANESTHETIZED DOG, British Journal of Pharmacology, 112, 1994, pp. 210000074-210000074
Authors:
WALLIS RM
ALKER D
BURGES RA
CROSS PE
GREENGRASS PM
MCINTYRE P
QUINN P
Citation: Rm. Wallis et al., UK-84,149 - A NOVEL GUT-SELECTIVE SPASMOLYTIC WITH CALCIUM-ANTAGONISTACTIVITY, British Journal of Pharmacology, 112, 1994, pp. 210000075-210000075
Authors:
WALLIS RM
ALKER D
BURGES RA
CROSS PE
NEWGREEN DT
QUINN P
Citation: Rm. Wallis et al., ZAMIFENACIN - A NOVEL GUT SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST, British Journal of Pharmacology, 109, 1993, pp. 160000036-160000036
Citation: P. Quinn et al., ZAMIFENACIN - A POTENT AND SELECTIVE MUSCARINIC-M(3) ANTAGONIST IN-VIVO, British Journal of Pharmacology, 109, 1993, pp. 160000037-160000037